Screening for inborn errors of metabolism among newborns with metabolic disturbance and/or neurological manifestations without determined cause

Authors

  • Allan Chiaratti de Oliveira Universidade Federal de São Paulo/Escola Paulista de Medicina
  • Amélia Miyashiro Nunes dos Santos Universidade Federal de São Paulo/Escola Paulista de Medicina
  • Ana Maria Martins Universidade Federal de São Paulo/Escola Paulista de Medicina
  • Vâniia D’Almeida Universidade Federal de São Paulo/Escola Paulista de Medicina

Keywords:

Inborn Errors of Metabolism, Inherited Metabolic Disorders, Newborns, Urinary Screening

Abstract

CONTEXT: Inborn Errors of Metabolism are hereditary affections resulting from incompetence inenzymatic reactions of intermediary metabolism. At present, several hundred hereditary metabolic disturbances are known, many of which correspond to severe life-threateningdisorders. OBJECTIVE:The early detection of carriers has motivated the screening for the sedisturbance samong newborns at the Neonatal Unit of Hospital São Paulo, in an attempt toinitiate support treatment,when available, before clinical manifestations become evident. DESIGN: Prospective study of risk patients. SETTING: Laboratory for Inborn Errors of Metabolism at the Center for Medical Genetics of the Departments of Pediatrics and Morphology of Universidade Federal de São Paulo/Escola Paulista de Medicina. Newborn care unit atatertiary care hospital. PARTICIPANTS: 101 children admitted into the Neonatal Unit were included in this study by presenting hypoglycemia, metabolic acidosis, jaundice, difficulty in gaining weight, diarrhea, vomiting, hepato-and/or splenomegaly, cataracts, apnea, convulsions, hypo- or hypertonia. DIAGNOSTIC TESTS: Tests routinely utilized, performed for qualitative research of abnormal substances excreted in the urine in situations of metabolic disorder. RESULTS: Children were included in the study mainly because of presenting hypoglycemia, jaundice and metabolicacidosis. Sixty-four newborns presente dat least one positive test result. Most of the positivity was due to transitory metabolic alterations of the newborn, such as the case of Transitory Neonatal Tyrosinemia, presented by 29 patients. Nine infants were referred to the Center for Medical Genetics of Universidade Federal de São Paulo for continuation of the diagnostic investigation. For three of them, the test sapplied permitted us to formulatea diagnostic hypothesis of mucopolysaccharidosis, tyrosinemia typeIandnon-ketotichyperglycinemia, respectively. CONCLUSIONS: The high positivity observed in the tests reflects the newborn’s ownmetabolicimmaturity. The selection of 9% of the studied cases for out patient follow- up confirms that Inborn Errors of Metabolism must be suspected whenever a patient presents metabolic disturbances or neurological manifestations with out a determined cause. They should be research edinparallel with the other diagnostic possibilities and not just taken to be exceptional diagnoses.

Downloads

Download data is not yet available.

Author Biographies

Allan Chiaratti de Oliveira, Universidade Federal de São Paulo/Escola Paulista de Medicina

Postgraduate Medical Student, Universidade Federal de São Paulo/Escola Paulista de Medicina, São Paulo, Brazil.

Amélia Miyashiro Nunes dos Santos, Universidade Federal de São Paulo/Escola Paulista de Medicina

MD, MSc. Discipline of Neonatal Pediatrics, Department of Pediatrics, Federal Universidade Federal de São Paulo/Escola Paulista de Medicina, São Paulo, Brazil.

Ana Maria Martins, Universidade Federal de São Paulo/Escola Paulista de Medicina

MD, PhD. Center for Medical Genetics, Discipline of General Pediatrics, Department of Pediatrics, Universidade Federal de São Paulo/Escola Paulista de Medicina, São Paulo, Brazil.

Vâniia D’Almeida, Universidade Federal de São Paulo/Escola Paulista de Medicina

PhD. Center for Medical Genetics, Discipline of General Pediatrics, Department of Pediatrics, Universidade Federal de São Paulo/Escola Paulista de Medicina, São Paulo, Brazil.

References

Beaudet AL, Scriver CR, Sly WS, Valle D. Genetics, biochemistry and molecular bases of variant human phenotypes. In: Beaudet AL, Scriver CR, Sly WS, Valle W, editors. The metabolic bases of inherited Deseasedisease on CD-ROM. 7th edition. New York: McGraw-Hill Book Company; 1995.

Goodman SI. Inherited metabolic disease in the newborn: approach to diagnosis and treatment. Adv Pediatr 1986;33:197-224.

Zschocke J, Hoffmann GF. Vademecum metabolicum: manual of metabolic pediatrics. Milupa. 1st ed. Stuttgart: Schttauer; 1999.

Hoffmann GF. Selective screening for inborn errors of metabolism: past, present and future. Eur J Pediatr 1994;153(Suppl 1):S2-S8.

Duran M, Dorland L, Wadman SK, Berger R. Group tests for selective screening of inborn errors of metabolism. Eur J Pediatr 1994;153(Suppl 1):S27-S32.

Shih VE. Introduction and summary of clinical findings in inborn errors of metabolism. In: Shih VE, editor. Laboratory techniques for the detection of hereditary metabolic disorders. 1st Edition. Boca Raton, Flórida: CRC Press; 1973:1-10.

Synnes AR. Use of the laboratory in prediction of outcome in the high-risk newborn. Clinical Chemistry 1997;43(1):243-8.

Anonymous. Serving the family from birth to the medical home. A report from the Newborn Screening Task Force convened in Wasshington DC, May 10-11, 1999. Pediatrics 2000;106(2 Pt 2):383-427.

Treacy E, Childs B, Scriver CR. Response to Treatement in hereditary metabolic disease: 1993 survey and 10-year comparison. Am J Hum Genet 1995;56:359-67.

Green ED, Cox DR, Myers RM. The Human Genome Project and its impact on the study of human disease. In: Beaudet AL, Scriver CR, Sly WS, Valle W, editors. The metabolic bases of inherited disease on CD-ROM. 7th edition. New York: McGraw-Hill Book Company; 1995.

Sanseverino MTV, Wajner M, Giugliani R. Aplicação de um protocolo clínico-laboratorial de erros inatos do metabolismo em crianças gravemente enfermas. Jornal de Pediatria 2000;76(5):375-82.

Blau N, Blaskovics ME, Duran M. Simple tests in urine and blood. In: Blau N, Blaskovics ME, Duran M, editors. Physician’s guide to the laboratory diagnosis of metabolic diseases. 1st Edition. London: Chapman & Hall Medical; 1996:3-11.

Delascio D, Guarniento A. Diagnóstico em obstetricia. São Paulo: Sarvier; 1981:271-81.

Dubowitz LMS, Dubowitz V, Goldberg C. Clinical assessment of gestational age in the newborn infant. J Pediatr 1970;77:1-10.

World Health Organization. Recomended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths. Acta Obstet Gynecol Scand 1977;56:247-53.

Battaglia FC, Lubchenko LO. A practical classification of newborn infants by weight and gestational age. J Pediatr 1967;71:159-63.

Buist N. Set of simple side-room urine tests for detection of inborn errors of metabolism. British Med J 1968;2:745-9.

Giorgio AJ, Luhbi LL. A rapid screening test for the detection of congenital methylmalonic aciduria in infancy. Am J Clin Path 1968;39(8):374-9.

Thomas GH, Howell RR. Selected screening tests for genetic metabolic diseases. Chicago: Yearbook Medical Publishers; 1973:36.

Efron ML, Young D, Moser HW, MacCready RA. A simple chromatographic screening test for the detection of disorders of amino acid metabolism: a technique using whole blood or urine collected on filter paper. N Engl J Med 1964;270:1378-83.

Shih VE, Mandel R, Sheinhait I. General metabolic screening tests. In: Hommes FA, editor. Techniques in diagnostic human biochemical genetics: a laboratory manual. Wiley-Liss; 1991:46-68.

Mitchell GA, Lambert M, Tanguay RM. Hypertyrosinemia. In: Beaudet AL, Scriver CR, Sly WS, Valle W, editors. The metabolic bases of inherited disease on CD-ROM. 7th edition. New York: McGraw-Hill Book Company; 1995.

Komrower GM, Robins AJ. Plasma amino acid disturbance in infancy I: hypermethioninemia and transient tyrosinemia. Arch Dis Child 1969;44:418-21.

Morris AF, Holton JB, Burman D, Colley JRT. Phenylalanine and tyrosine levels in newborn screening blood samples. Arch Dis Childh 1983;58:271-5.

Driscoll DJ, Jabs EW, Alcorn D, Maumenee IH, Brusilow SW, Valle D. Corneal tyrosine crystals in transient neonatal tyrosinemia. Clin Lab Obs 1988;113(1):91-3.

Blau N, Beck M, Matern D. Tetrahydrobiopterin induced neonatal tyrosinemia. Eur J Pediatr 1996;155(9):832.

Jardim LB. Tirosinemia neonatal transitória: doença ou variação do normal? Jornal de Pediatria 1998;74(6):431-2.

Partington MW, Campbell D, Kuyek J, Mehlomakulu M. Motor activity in early life: premature babies with neonatal tyrosinemia; a pilot study. Biol Neonate 1971;18(1):121-8.

Mamunes P, Prince PE, Thornton NH, Hunt PA, Hitchcock ES. Intellectual deficits after transient tyrosinemia in the term neonate. Pediatrics 1976;57:675-80.

Partington MW, Delayaye DJ, Masotti RE, Read JR, Roberts B. Neonatal Tirosinemiatyrosinemia: a follow-up study. Arch Dis Childh 1968;43:195-9.

Jardim LB, Hauck S, Forcelini C, Weber E, Knijnik M, Giugliani R. Transient tyrosinemia of newborn: intellectual deficits revisited. II Congreso Latinoamericano de Errores Innatos del Metabolismo y Pesquisa Neonatal; 1999:92-3.

Nutrition Committee, Canadian Pediatric Society. Nutrition needs and feeding of premature infants. Can Med Assoc J 1995;152(11):1756-85.

Scott PH, Berger HM, Wharton BA. Growth velocity and plasma amino acid in the newborn. Pediatr Res 1985;19:446-50.

Wharton BA, Scott PW. Distinctive aspects of metabolism and nutrition in infancy. Clinical Biochemistry 1996;29(5):419-28.

Wajner M, Wannamacher CMD, Gaidzinsk D, et al. Detection of inborn errors of metabolism in patients of pediatric intensive care units of Porto Alegre, Brazil: comparison of the prevalence of such disturbances in a selected and an unselected sample. Rev Brasil Genet 1986;IX(2):331-40.

Coelho JC, Wajner M, Burin MG, Vargas CR, Giugliani R. Selective screening of 10,000 high-risk Brazilian patients for the detection of inborn errors of metabolism. Eur J Pediatr 1997;156:650-4.

Pereira MB, Conceição GC, Coelho JC, Wajner M, Giugliani R. Detection of metabolic disorders in high-risk patients. Arq Neuropsiquiatr 1997;55(2):209-12.

Simoni RL, Oliveira CPH, Grassiano DM, et al. Screening for inborn errors of metabolism in high-risk children from Rio de Janeiro, Brazil. Early Hum Dev 1998;50:305-11.

Downloads

Published

2001-09-09

How to Cite

1.
Oliveira AC de, Santos AMN dos, Martins AM, D’Almeida V. Screening for inborn errors of metabolism among newborns with metabolic disturbance and/or neurological manifestations without determined cause. Sao Paulo Med J [Internet]. 2001 Sep. 9 [cited 2025 Mar. 15];119(5):160-4. Available from: https://periodicosapm.emnuvens.com.br/spmj/article/view/2779

Issue

Section

Original Article